Foresee Pharmaceuticals Co Ltd (6576)

TPEX
Currency in TWD
76.30
0.00(0.00%)
Closed
6576 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
Day's Range
75.6076.40
52 wk Range
68.40107.50
Key Statistics
Edit
Bid/Ask
103.50 / 104.00
Prev. Close
76.3
Open
76.4
Day's Range
75.6-76.4
52 wk Range
68.4-107.5
Volume
74
Average Volume (3m)
14.84K
1-Year Change
-21.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6576 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
126.50
Upside
+65.79%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Foresee Pharmas Company Profile

Foresee Pharmaceuticals Co., Ltd. operates as biopharmaceutical company in the United States, China, and Europe. The company’s stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary emphysema; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, and acute respiratory distress syndrome in COVID-19 patients; and FP-045, a selective aldehyde dehydrogenase (ALDH2) activator that completed Phase I clinical study for the treatment of fanconi anemia, as well as FP-040, an ALDH2 activator to treat central nervous system diseases. Foresee Pharmaceuticals Co., Ltd. was incorporated in 2013 and is based in Taipei, Taiwan.

Compare 6576 to Peers and Sector

Metrics to compare
6576
Peers
Sector
Relationship
P/E Ratio
−12.7x−63.7x−0.6x
PEG Ratio
−1.75−1.070.00
Price/Book
16.8x2.8x2.6x
Price / LTM Sales
34.1x6.6x3.1x
Upside (Analyst Target)
65.8%0.0%55.1%
Fair Value Upside
Unlock−10.6%9.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 126.50

(+65.79% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-1.99 / -1.67
Revenue / Forecast
80.00M / 112.00M
EPS Revisions
Last 90 days

FAQ

What Is the Foresee Pharmas (6576) Stock Price Today?

The Foresee Pharmas stock price today is 76.30.

What Stock Exchange Does Foresee Pharmas Trade On?

Foresee Pharmas is listed and trades on the TPEX stock exchange.

What Is the Stock Symbol for Foresee Pharmas?

The stock symbol for Foresee Pharmas is "6576."

What Is the Foresee Pharmas Market Cap?

As of today, Foresee Pharmas market cap is 11.81B.

What is Foresee Pharmas Earnings Per Share?

The Foresee Pharmas EPS is -6.84.

What Is the Next Foresee Pharmas Earnings Date?

Foresee Pharmas will release its next earnings report on 18 Feb 2025.

From a Technical Analysis Perspective, Is 6576 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.